Anixa Biosciences is trading at $3.16, up 5.69%, with biotech sector strength a possible supporting factor.

  • Biotech ETF XBI was up 2.13%, but this does not confirm a direct cause of the move.
  • No clear company-specific announcement explaining the November 3 move was found; the latest listed company release was October 26.
  • A CEO purchase disclosed November 3 concerned a transaction dated October 30 and does not establish the cause of today’s gain.